Advancing pharmacy and healthcare with virtual digital technologies
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Digitalisation of the healthcare sector promises to revolutionise patient healthcare globally. From the different technologies, cyber tools including artificial intelligence, blockchain, virtual, and augmented reality, to name but a few, are providing significant benefits to patients and the pharmaceutical sector alike, ranging from improving access to clinicians and medicines, as well as improving real-time diagnoses and treatments. Indeed, it is envisioned that such technologies will communicate together in real-time, as well as with their physical counterparts, to create a large-scale, cyber healthcare system. Despite the significant benefits that cyber-based digital health technologies can bring to patient care, a number of challenges still remain, ranging from data security to acceptance within the healthcare sector. This review provides a timely account of the benefits and challenges of cyber-based health interventions, as well an outlook on how such technologies can be transitioned from research-focused towards real-world healthcare and pharmaceutical applications to transform treatment pathways for patients worldwide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deep Residual Learning for Image Recognition
He, K., Zhang, X., Ren, S., & Sun, J. (2016) · 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR) · doi:10.1109/cvpr.2016.90 · Cited by 235,474
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
High-performance medicine: the convergence of human and artificial intelligence
Topol, E. J. (2019) · Nature Medicine · doi:10.1038/s41591-018-0300-7 · Cited by 10,450 · cited 9×
“MediLedger has the aim to protect the pharmaceutical supply-chain end-to-end and enable compliance with the FDA Drug Supply Chain Security Act (DSCSA).”
BackgroundInfluentialAzuma, R. T. (1997) · Presence: Teleoperators and Virtual Environments · doi:10.1162/pres.1997.6.4.355 · Cited by 10,121
An Overview of Blockchain Technology: Architecture, Consensus, and Future Trends
Zheng, Z., Xie, S., Dai, H., Chen, X., & Wang, H. (2017) · 2017 IEEE International Congress on Big Data (BigData Congress) · doi:10.1109/bigdatacongress.2017.85 · Cited by 4,515
Applications of machine learning in drug discovery and development
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0024-5 · Cited by 3,228
Highly accurate protein structure prediction for the human proteome
Tunyasuvunakool, K., Adler, J., Wu, Z., Green, T., Zielinski, M., Žídek, A., Bridgland, A., Cowie, A., Meyer, C., Laydon, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03828-1 · Cited by 3,025 · cited 2×
“(D) correlation between prediction confidence (pLDDT) and agreement with an experimentally validated structure (lDDT-Cα) for a subsample of proteins from the human proteome [83].”
BackgroundInformation bias in health research: definition, pitfalls, and adjustment methods
Althubaiti, A. (2016) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s104807 · Cited by 3,018
Characterising the Digital Twin: A systematic literature review
Jones, D., Snider, C., Nassehi, A., Yon, J., & Hicks, B. (2020) · CIRP Journal of Manufacturing Science and Technology · doi:10.1016/j.cirpj.2020.02.002 · Cited by 2,422 · cited 1×
“Developing the aforementioned virtual technologies can streamline the consolidation of digital twinning; the concept of virtually replicating the entire drug product cycle using data from the physical world [203].”
BackgroundEstimation of clinical trial success rates and related parameters
Wong, C. H., Siah, K. W., & Lo, A. W. (2019) · Biostatistics · doi:10.1093/biostatistics/kxx069 · Cited by 1,585
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473 · cited 1×
“Deep learning is another advanced ML technique showing good results in drug discovery programmes [78-81].”
BackgroundBenjamens, S., Dhunnoo, P., & Meskó, B. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-00324-0 · Cited by 1,215 · cited 10×
“MediLedger has the aim to protect the pharmaceutical supply-chain end-to-end and enable compliance with the FDA Drug Supply Chain Security Act (DSCSA).”
BackgroundInfluentialBlockchain technology in healthcare: a systematic review
Agbo, C. C., Mahmoud, Q. H., & Eklund, J. M. (2019) · Healthcare · doi:10.3390/healthcare7020056 · Cited by 1,131
Unsupervised word embeddings capture latent knowledge from materials science literature
Tshitoyan, V., Dagdelen, J., Weston, L., Dunn, A., Rong, Z., Kononova, O., Persson, K. A., Ceder, G., & Jain, A. (2019) · Nature · doi:10.1038/s41586-019-1335-8 · Cited by 1,123 · cited 1×
“For example, NLP was recently used to discover new material through interpreting abstracts of articles [104].”
MethodBaranowski, T., Buday, R., Thompson, D. I., & Baranowski, J. (2008) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2007.09.027 · Cited by 998 · cited 1×
“From a treatment perspective, technologies such as VR and gamification are leading to more patients being treated with digital interventions [19, 20].”
BackgroundMachine learning in chemoinformatics and drug discovery
Lo, Y.-C., Rensi, S. E., Torng, W., & Altman, R. B. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.05.010 · Cited by 960
Observational studies: Cohort and case-control studies
Song, J. W., & Chung, K. C. (2010) · Plastic and Reconstructive Surgery · doi:10.1097/prs.0b013e3181f44abc · Cited by 948
Video consultations for covid-19
Greenhalgh, T., Wherton, J., Shaw, S., & Morrison, C. (2020) · BMJ · doi:10.1136/bmj.m998 · Cited by 866
Automated design of ligands to polypharmacological profiles
Besnard, J., Ruda, G. F., Setola, V., Abecassis, K., Rodriguiz, R. M., Huang, X.-P., Norval, S., Sassano, M. F., Shin, A. I., Webster, L. A., et al. (2012) · Nature · doi:10.1038/nature11691 · Cited by 832 · cited 1×
“Active learning has been applied to design novel ligands with multiple pharmacological targets, identify structurally diverse molecules with target hits, and predict off-target drug effects on proteins [75-77].”
BackgroundA Systematic Review of the Use of Blockchain in Healthcare
Hölbl, M., Kompara, M., Kamišalić, A., & Nemec Zlatolas, L. (2018) · Symmetry · doi:10.3390/sym10100470 · Cited by 780
Blockchain Technologies: The Foreseeable Impact on Society and Industry
Aste, T., Tasca, P., & Di Matteo, T. (2017) · Computer · doi:10.1109/mc.2017.3571064 · Cited by 676
Artificial intelligence for clinical trial design
Harrer, S., Shah, P., Antony, B., & Hu, J. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.05.005 · Cited by 672 · cited 2×
“Like the medical field, the pharmaceutical industry is rapidly adopting AI, especially ML, with applications at every stage of drug development from compound discovery to post-marketing surveillance and patient support [3, 49-55].”
BackgroundBini, S. A. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.02.067 · Cited by 670
Autonomous Cars: Research Results, Issues, and Future Challenges
Hussain, R., & Zeadally, S. (2019) · IEEE Communications Surveys & Tutorials · doi:10.1109/comst.2018.2869360 · Cited by 631 · cited 1×
“At present, no AI software has reached the level of general intelligence, though there are many instances of machines that combine different types of AI to conduct multiple intelligent tasks simultaneously; for example driverless cars can employ computer vision, sensors, robotics, and NLP instantaneously [38].”
BackgroundExploiting machine learning for end-to-end drug discovery and development
Ekins, S., Puhl, A. C., Zorn, K. M., Lane, T. R., Russo, D. P., Klein, J. J., Hickey, A. J., & Clark, A. M. (2019) · Nature Materials · doi:10.1038/s41563-019-0338-z · Cited by 578 · cited 2×
“17 ML has been proposed as an end-to-end enabler for the entire drug development pathway [86].”
BackgroundClinical trials: The challenge of recruitment and retention of participants
Gul, R. B., & Ali, P. A. (2010) · Journal of Clinical Nursing · doi:10.1111/j.1365-2702.2009.03041.x · Cited by 449 · cited 1×
“Additionally, the number of recruitment dropouts may be lessened, which is one of the leading causes of trial failure [119].”
BackgroundEmerging materials intelligence ecosystems propelled by machine learning
Batra, R., Song, L., & Ramprasad, R. (2020) · Nature Reviews Materials · doi:10.1038/s41578-020-00255-y · Cited by 446
Drugs, Devices, and the FDA: Part 1
Van Norman, G. A. (2016) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2016.03.002 · Cited by 366
DeVito, N. J., Bacon, S., & Goldacre, B. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33220-9 · Cited by 336 · cited 1×
“9% of clinical trials are compliant with this requirement within the 1 year deadline [143].”
MethodTreatment of acrophobia in virtual reality: The role of immersion and presence
Krijn, M., Emmelkamp, P. M. G., Biemond, R., de Wilde de Ligny, C., Schuemie, M. J., & van der Mast, C. A. P. G. (2004) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(03)00139-6 · Cited by 320
Meyerbröker, K., & Emmelkamp, P. M. G. (2010) · Depression and Anxiety · doi:10.1002/da.20734 · Cited by 290
Nimri, R., Battelino, T., Laffel, L. M., Slover, R. H., Schatz, D., Weinzimer, S. A., Dovc, K., Danne, T., Phillip, M., NextDREAM Consortium, et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1045-7 · Cited by 242
Let’s talk about sex: Differences in drug therapy in males and females
Madla, C. M., Gavins, F. K. H., Merchant, H. A., Orlu, M., Murdan, S., & Basit, A. W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.014 · Cited by 167
Self-citationPrototype of running clinical trials in an untrustworthy environment using blockchain
Wong, D. R., Bhattacharya, S., & Butte, A. J. (2019) · Nature Communications · doi:10.1038/s41467-019-08874-y · Cited by 160 · cited 1×
“To overcome these challenges, and to ensure credibility in scientific findings and to maintain trust and confidence in clinical trial results, blockchain has been explored as a strategy which could be used to readily collect data real-time in a secure and unfalsifiable manner [144, 145].”
BackgroundMoorthy, V. S., Karam, G., Vannice, K. S., & Kieny, M.-P. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001819 · Cited by 155 · cited 1×
“Whilst advances have been made in this area, for example by the World Health Organisation (WHO) requiring all clinical trials to make their methods and results freely available [142], a recent study by the Lancet identified that only 40.”
MethodArtificial Intelligence and Machine Learning Applied at the Point of Care
Angehrn, Z., Haldna, L., Zandvliet, A. S., Gil Berglund, E., Zeeuw, J., Amzal, B., Cheung, S. Y. A., Polasek, T. M., Pfister, M., Kerbusch, T., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00759 · Cited by 93
Boosting drug bioavailability in men but not women through the action of an excipient
Mai, Y., Ashiru-Oredope, D. A. I., Yao, Z., Dou, L., Madla, C. M., Taherali, F., Murdan, S., & Basit, A. W. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119678 · Cited by 28
Self-citationAn architecture for Naval telemedicine
Chimiak, W. J., Rainer, R. O., Chimiak, J. M., & Martinez, R. (1997) · IEEE Transactions on Information Technology in Biomedicine · doi:10.1109/4233.594058 · Cited by 15 · cited 1×
“, medical consultations, education, treatment, monitoring and diagnoses) remotely [150].”
Background
Research works printed but not linked: 138
- Hassanalieragh, 2015, Health Monitoring and Management Using Internet-of-Things (IoT) Sensing with Cloud-Based Processing: Opportunities and Challenges, Proceedings - 2015 IEEE International Conference on Services Computing, SCC, 2015, 285, 10.1109/SCC.2015.47 · DOI · Paper page
- Elbadawi, 2020, Advanced machine-learning techniques in drug discovery, Drug Discov. Today, 26, 769, 10.1016/j.drudis.2020.12.003 · DOI · Paper page
- Schuhmacher, 2020, The upside of being a digital pharma player, Drug Discov. Today, 25, 1569, 10.1016/j.drudis.2020.06.002 · DOI · Paper page
- Schuhmacher, 2019, The Art of Virtualizing Pharma R&D, Drug Discov. Today, 24, 2105, 10.1016/j.drudis.2019.07.004 · DOI
- Fedorov, 2021, Towards practical applications in quantum computational biology, Nature Computational, Science, 1, 114
- Wang, 2021, Computational pharmaceutics - A new paradigm of drug delivery, J. Control. Release, 338, 119, 10.1016/j.jconrel.2021.08.030 · DOI · Paper page
- Trenfield, 2019, Track-and-trace: Novel anti-counterfeit measures for 3D printed personalized drug products using smart material inks, Int. J. Pharm., 567, 118443, 10.1016/j.ijpharm.2019.06.034 · DOI
- Medina, 2016, Counterfeit medicines in Peru: a retrospective review (1997–2014), BMJ Open, 6, 10.1136/bmjopen-2015-010387 · DOI
- Clark, 2018, Blockchain, IP and the pharma industry—how distributed ledger technologies can help secure the pharma supply chain, J. Intellectual Property Law & Practice, 13, 531, 10.1093/jiplp/jpy069 · DOI
- Singh, 2020, Internet of Things Based Blockchain for Temperature Monitoring and Counterfeit Pharmaceutical Prevention, Sensors, 20, 3951, 10.3390/s20143951 · DOI · Paper page
- Amazon, Introducing Amazon Pharmacy: Prescription Medications Delivered, 2020. https://press.aboutamazon.com/news-releases/news-release-details/introducing-amazon-pharmacy-prescription-medications-delivered.
- Gulliford, 1998, Using telemedicine technology for pharmaceutical services to ambulatory care patients, Am. J. Health-Syst. Pharm., 55, 1512, 10.1093/ajhp/55.14.1512 · doi:10.1093/ajhp/55.14.1512
- Kichloo, 2020, Telemedicine, the current COVID-19 pandemic and the future: a narrative review and perspectives moving forward in the USA, Fam Med Community Health, 8, e000530, 10.1136/fmch-2020-000530 · DOI · Paper page
- Papastergiou, 2009, Exploring the potential of computer and video games for health and physical education: A literature review, Comput. Educ., 53, 603, 10.1016/j.compedu.2009.04.001 · DOI · Paper page
- Motraghi, 2014, Virtual reality exposure therapy for the treatment of posttraumatic stress disorder: a methodological review using CONSORT guidelines, J. Clin. Psychol., 70, 197, 10.1002/jclp.22051 · DOI · Paper page
- Halic, 2014, MoMiReS: Mobile mixed reality system for physical & occupational therapies for hand and wrist ailments, IEEE Innovations in Technology Conference, 2014, 1
- Yang, 2021, A Novel Mobile Application for Medication Adherence Supervision Based on AR and OpenCV Designed for Elderly Patients, Int. Conf. Human-Computer Interaction, Springer, 335
- Hussein G., Kawahara N., Adaptive and longitudinal pharmaceutical care instruction using an interactive voice response/text-to-speech system, American journal of pharmaceutical education, 70 (2006) 37-37. · doi:10.1016/s0002-9459(24)07679-4
- Liu, 2018, Using virtual reality for drug discovery: a promising new outlet for novel leads, Expert Opin. Drug Discov., 13, 1103, 10.1080/17460441.2018.1546286 · DOI
- Eleftheriadis, 2021, Modular design principle based on compartmental drug delivery systems, Adv. Drug Deliv. Rev., 178, 10.1016/j.addr.2021.113921 · DOI
- Awad, 2021, Connected Healthcare: Improving Patient Care using Digital Health Technologies, Adv. Drug Deliv. Rev., 178, 113958, 10.1016/j.addr.2021.113958 · DOI · Paper page
- Henstock, 2019, Artificial Intelligence for Pharma: Time for Internal Investment, Trends Pharmacol. Sci., 40, 543, 10.1016/j.tips.2019.05.003 · DOI
- Pollard, 2021, Electrochemical biosensors: a nexus for precision medicine, Drug Discov Today, 26, 69, 10.1016/j.drudis.2020.10.021 · DOI
- Ong, 2021, Optical biosensors - Illuminating the path to personalized drug dosing, Biosens. Bioelectron., 188, 113331, 10.1016/j.bios.2021.113331 · DOI
- Collobert, 2011, Natural language processing (almost) from scratch, J. Machine Learning Research, 12, 2493
- Zemmar, 2020, The rise of robots in surgical environments during COVID-19, Nature, Machine Intelligence, 2, 566
- Mesko, 2020, A short guide for medical professionals in the era of artificial intelligence, NPJ Digit Med, 3, 126, 10.1038/s41746-020-00333-z · DOI · Paper page
- Badillo, 2020, An Introduction to Machine Learning, Clin. Pharmacol. Ther., 107, 871, 10.1002/cpt.1796 · DOI · Paper page
- May, 2021, Eight ways machine learning is assisting medicine, Nat. Med., 27, 2, 10.1038/s41591-020-01197-2 · DOI
- FDA approves stroke-detecting AI software, Nature Biotechnology, 36 (2018) 290-290. · DOI
- Golan, 2020, AI-powered stroke triage system performance in the wild, J. Experimental Stroke Translational Medicine, 12
- Abdelrahman, 2021, Convolutional neural networks for breast cancer detection in mammography: A survey, Comput. Biol. Med., 131, 104248, 10.1016/j.compbiomed.2021.104248 · DOI · Paper page
- Knoops P.G.M., Papaioannou A., Borghi A., Breakey R.W.F., Wilson A.T., Jeelani O., Zafeiriou S., Steinbacher D., Padwa B.L., Dunaway D.J., Schievano S., A machine learning framework for automated diagnosis and computer-assisted planning in plastic and reconstructive surgery, Scientific reports, 9 (2019) 13597-13597. · DOI
- Ravi, 2017, Deep Learning for Health Informatics, IEEE J. Biomed. Health. Inf., 21, 4, 10.1109/JBHI.2016.2636665 · DOI · Paper page
- Bannigan, 2021, Machine learning directed drug formulation development, Adv. Drug Deliv. Rev., 175, 113806, 10.1016/j.addr.2021.05.016 · DOI · Paper page
- Bhhatarai, 2019, Opportunities and challenges using artificial intelligence in ADME/Tox, Nat. Mater., 18, 418, 10.1038/s41563-019-0332-5 · DOI · Paper page
- Chan, 2019, Advancing Drug Discovery via Artificial Intelligence, Trends Pharmacol. Sci., 40, 592, 10.1016/j.tips.2019.06.004 · DOI · Paper page
- Elbadawi, 2021, Disrupting 3D printing of medicines with machine learning, Trends Pharmacol. Sci., 42, 745, 10.1016/j.tips.2021.06.002 · DOI
- Elbadawi, 2020, M3DISEEN: A novel machine learning approach for predicting the 3D printability of medicines, Int. J. Pharm., 590, 10.1016/j.ijpharm.2020.119837 · DOI · Paper page
- Lester, 2021, Human versus machine editing of electronic prescription directions, J. Am. Pharm. Assoc., 61, 484, 10.1016/j.japh.2021.02.006 · DOI
- Nimri, 2020, Decision Support Systems for Insulin Treatment Adjustment in People with Type 1 Diabetes, Pediatr Endocrinol Rev, 17, 170
- Nimri, 2018, Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physicians, Diabetes Obes. Metab., 20, 2458, 10.1111/dom.13408 · DOI
- Chen, 2017, Developing an in silico pipeline for faster drug candidate discovery: Virtual high throughput screening with the Signature molecular descriptor using support vector machine models, Chem. Eng. Sci., 159, 31, 10.1016/j.ces.2016.02.037 · DOI
- Ashiru, 2008, Polyethylene Glycol 400 Enhances the Bioavailability of a BCS Class III Drug (Ranitidine) in Male Subjects but Not Females, Pharm. Res., 25, 2327, 10.1007/s11095-008-9635-y · DOI
- McCoubrey, 2021, Predicting drug-microbiome interactions with machine learning, Biotechnol. Adv., 54, 107797, 10.1016/j.biotechadv.2021.107797 · DOI · Paper page
- Ding, 2021, DeepBAR: A Fast and Exact Method for Binding Free Energy Computation, J. Physical Chem. Lett., 12, 2509, 10.1021/acs.jpclett.1c00189 · DOI
- Mamoshina, 2018, Machine Learning on Human Muscle Transcriptomic Data for Biomarker Discovery and Tissue-Specific Drug Target Identification, Front. Genet., 9, 242, 10.3389/fgene.2018.00242 · DOI · Paper page
- McCoubrey, 2021, Machine Learning Uncovers Adverse Drug Effects on Intestinal Bacteria, Pharmaceutics, 13, 1026, 10.3390/pharmaceutics13071026 · DOI
- Ståhl, 2019, Deep Reinforcement Learning for Multiparameter Optimization in de novo Drug Design, J. Chem. Inf. Model., 59, 3166, 10.1021/acs.jcim.9b00325 · DOI · Paper page
- Yamada, 2019, Predicting Materials Properties with Little Data Using Shotgun Transfer Learning, ACS Cent. Sci., 5, 1717, 10.1021/acscentsci.9b00804 · DOI · Paper page
- Chen, 2020, Generative Deep Neural Networks for Inverse Materials Design Using Backpropagation and Active Learning, Adv. Sci., 7, 1902607, 10.1002/advs.201902607 · DOI · Paper page
- Reker, 2019, Practical considerations for active machine learning in drug discovery, Drug Discovery Today: Technologies, 32-33, 73, 10.1016/j.ddtec.2020.06.001 · DOI
- Fujiwara, 2008, Virtual Screening System for Finding Structurally Diverse Hits by Active Learning, J. Chem. Inf. Model., 48, 930, 10.1021/ci700085q · doi:10.1021/ci700085q
- Kangas, 2014, Efficient discovery of responses of proteins to compounds using active learning, BMC Bioinf., 15, 143, 10.1186/1471-2105-15-143 · DOI
- Baskin, 2020, The power of deep learning to ligand-based novel drug discovery, Expert Opin. Drug Discov., 15, 755, 10.1080/17460441.2020.1745183 · DOI · Paper page
- Maragakis, 2020, A Deep-Learning View of Chemical Space Designed to Facilitate Drug Discovery, J. Chem. Inf. Model., 60, 4487, 10.1021/acs.jcim.0c00321 · DOI
- Bahi, 2018, Drug-Target Interaction Prediction in Drug Repositioning Based on Deep Semi-Supervised Learning, IFIP Adv. Information Communication Technology, 302
- Reker, 2015, Active-learning strategies in computer-assisted drug discovery, Drug Discovery Today, 20, 458, 10.1016/j.drudis.2014.12.004 · DOI · Paper page
- Li, 2015, Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology, Eur. J. Pharm. Biopharm., 94, 170, 10.1016/j.ejpb.2015.04.028 · DOI
- Manda, 2019, An Artificial Neural Network Approach to Predict the Effects of Formulation and Process Variables on Prednisone Release from a Multipartite System, Pharmaceutics, 11, 109, 10.3390/pharmaceutics11030109 · DOI
- Narayanan, 2021, Machine Learning for Biologics: Opportunities for Protein Engineering, Developability, and Formulation, Trends Pharmacol. Sci., 42, 151, 10.1016/j.tips.2020.12.004 · DOI · Paper page
- Lou, 2021, Applications of Machine Learning in Solid Oral Dosage Form Development, J. Pharm. Sci., 110, 3150, 10.1016/j.xphs.2021.04.013 · DOI
- Oishi, 2020, Creation of novel large dataset comprising several granulation methods and the prediction of tablet properties from critical material attributes and critical process parameters using regularized linear regression models including interaction terms, Int. J. Pharm., 577, 10.1016/j.ijpharm.2020.119083 · doi:10.1016/j.ijpharm.2020.119083
- Elbadawi, 2020, 3D printing tablets: Predicting printability and drug dissolution from rheological data, Int. J. Pharm., 590, 10.1016/j.ijpharm.2020.119868 · DOI
- Elbadawi, 2021, Harnessing Artificial Intelligence for the Next Generation of 3D Printed Medicines, Adv. Drug Deliv. Rev., 175, 10.1016/j.addr.2021.05.015 · DOI · Paper page
- O’Reilly, 2021, Machine Learning and Machine Vision Accelerate 3D Printed Orodispersible Film Development, Pharmaceutics, 13, 2187, 10.3390/pharmaceutics13122187 · DOI
- Muñiz Castro, 2021, Machine learning predicts 3D printing performance of over 900 drug delivery systems, J. Controlled Rel., 337, 530, 10.1016/j.jconrel.2021.07.046 · DOI · Paper page
- Miljković, 2021, Machine Learning Models for Human In Vivo Pharmacokinetic Parameters with In-House Validation, Mol. Pharm., 18, 4520, 10.1021/acs.molpharmaceut.1c00718 · DOI
- Wang, 2016, ADMET Evaluation in Drug Discovery Predicting hERG Blockers by Combining Multiple Pharmacophores and Machine Learning Approaches, Molecular Pharmaceutics, 13, 2855, 10.1021/acs.molpharmaceut.6b00471 · DOI
- Rohani, 2019, Drug-Drug Interaction Predicting by Neural Network Using Integrated Similarity, Sci. Rep., 9, 13645, 10.1038/s41598-019-50121-3 · DOI · Paper page
- Reker, 2020, Machine Learning Uncovers Food- and Excipient-Drug Interactions, Cell Reports, 30, 3710, 10.1016/j.celrep.2020.02.094 · DOI · Paper page
- Mai, 2019, Sex-dependence in the effect of pharmaceutical excipients: Polyoxyethylated solubilising excipients increase oral drug bioavailability in male but not female rats, Pharmaceutics, 11, 228, 10.3390/pharmaceutics11050228 · DOI
- Nabirotchkin, 2020, Next-generation drug repurposing using human genetics and network biology, Curr. Opin. Pharmacol., 51, 78, 10.1016/j.coph.2019.12.004 · DOI · Paper page
- Herrero-Zazo, 2013, The DDI corpus: An annotated corpus with pharmacological substances and drug–drug interactions, J. Biomed. Inform., 46, 914, 10.1016/j.jbi.2013.07.011 · DOI · Paper page
- Westphal, 2021, A machine learning method for defect detection and visualization in selective laser sintering based on convolutional neural networks, Addit. Manuf., 41
- Anwar, 2018, Study of the spatter distribution on the powder bed during selective laser melting, Addit. Manuf., 22, 86
- Zhang, 2019, Hybrid Machine Learning Method to Determine the Optimal Operating Process Window in Aerosol Jet 3D Printing, ACS Appl. Mater. Interfaces, 11, 17994, 10.1021/acsami.9b02898 · DOI
- Farhan, 2021, Real-time defect detection in 3D printing using machine learning, Mater. Today:. Proc., 42, 521
- Russell, 2019, Multifunctional motion-to-color janus transducers for the rapid detection of sepsis biomarkers in whole blood, Biosens. Bioelectron., 140, 10.1016/j.bios.2019.111346 · DOI
- Erenas, 2019, Real time monitoring of glucose in whole blood by smartphone, Biosens. Bioelectron., 136, 47, 10.1016/j.bios.2019.04.024 · DOI
- Pascucci, 2021, AI-based mobile application to fight antibiotic resistance, Nat. Commun., 12, 1173, 10.1038/s41467-021-21187-3 · DOI
- Haddad T.C., Helgeson J., Pomerleau K., Makey M., Lombardo P., Coverdill S., Urman A., Rammage M., Goetz M.P., LaRusso N., Impact of a cognitive computing clinical trial matching system in an ambulatory oncology practice, Journal of Clinical Oncology, 36 (2018) 6550-6550. · DOI · Paper page
- Karystianis G., Florez-Vargas O., Butler T., Nenadic G., A rule-based approach to identify patient eligibility criteria for clinical trials from narrative longitudinal records, JAMIA Open, 2 (2019) 521-527. · DOI
- Ni, 2019, A Real-Time Automated Patient Screening System for Clinical Trials Eligibility in an Emergency Department: Design and Evaluation, JMIR Med Inform, 7, e14185, 10.2196/14185 · DOI · Paper page
- Perry, 2018, Use of mobile devices to measure outcomes in clinical research, 2010–2016: a systematic literature review, Digital, Biomarkers, 2, 11
- Pandey, 2020, Implementing healthcare services on a large scale: Challenges and remedies based on blockchain technology, Health Policy Technology, 9, 69, 10.1016/j.hlpt.2020.01.004 · DOI
- Mackey, 2019, A Framework Proposal for Blockchain-Based Scientific Publishing Using Shared Governance, Frontiers Blockchain, 2, 19, 10.3389/fbloc.2019.00019 · DOI
- Hanson-Heine, 2020, Computational chemistry experiments performed directly on a blockchain virtual computer, Chem. Sci., 11, 4644, 10.1039/D0SC01523G · DOI
- Kosmarski, 2020, Blockchain Adoption in Academia: Promises and Challenges, J. Open Innovation: Technology, Market Complexity, 6, 117, 10.3390/joitmc6040117 · DOI
- Mackey, 2015, Counterfeit drug penetration into global legitimate medicine supply chains: a global assessment, The American journal of tropical medicine and hygiene, 92, 59, 10.4269/ajtmh.14-0389 · DOI
- Uddin, 2021, Blockchain Medledger: Hyperledger fabric enabled drug traceability system for counterfeit drugs in pharmaceutical industry, Int. J. Pharm., 597, 10.1016/j.ijpharm.2021.120235 · DOI · Paper page
- Nørfeldt, 2019, Cryptopharmaceuticals: Increasing the Safety of Medication by a Blockchain of Pharmaceutical Products, J. Pharm. Sci., 108, 2838, 10.1016/j.xphs.2019.04.025 · DOI
- Barba, 2020, Report on MediLedger blockchain network submitted to the FDA, Outsourcing-Pharma
- Lynch, 2019, Blockchain product verification solution launched, Outsourcing-Pharma
- Hosseini Bamakan, 2021, Blockchain-enabled pharmaceutical cold chain: Applications, key challenges, and future trends, J. Cleaner Prod., 302, 10.1016/j.jclepro.2021.127021 · DOI · Paper page
- Hulea, 2018, Pharmaceutical cold chain management: Platform based on a distributed ledger, 2018 IEEE International Conference on Automation, Quality and Testing, Robotics (AQTR), 1
- Kim, 2020, Implementation of a Blood Cold Chain System Using Blockchain Technology, Applied Sciences, 10, 3330, 10.3390/app10093330 · DOI
- Gupta, 2013, Fraud and misconduct in clinical research: A concern, Perspect, Clin Res, 4, 144
- Benchoufi, 2019, From Clinical Trials to Highly Trustable Clinical Trials: Blockchain in Clinical Trials, a Game Changer for Improving Transparency?, Frontiers in Blockchain, 2, 23, 10.3389/fbloc.2019.00023 · DOI
- Omar, 2020, Ensuring protocol compliance and data transparency in clinical trials using Blockchain smart contracts, BMC Med. Res. Method., 20, 224, 10.1186/s12874-020-01109-5 · DOI
- Benchoufi, 2017, Blockchain protocols in clinical trials: Transparency and traceability of consent, F1000Res, 6, 66, 10.12688/f1000research.10531.4 · DOI
- Albanese, 2020, Dynamic consent management for clinical trials via private blockchain technology, Journal of Ambient Intelligence and Humanized, Computing, 11, 4909
- K. F A., o S., F S., IoT technologies combining glucose control with physiological signal: comparative study, 2020 International Conference on Electrical Engineering (ICEE), 2020, pp. 1-6. · DOI
- Ghezzi, 2017, Oral healthcare systems for an ageing population: concepts and challenges, Int. Dent. J., 67, 26, 10.1111/idj.12343 · DOI
- Amalberti, 2016, Preparing national health systems to cope with the impending tsunami of ageing and its associated complexities: Towards more sustainable health care, Int. J. Qual. Health Care, 28, 412, 10.1093/intqhc/mzw021 · DOI
- Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, The Lancet, 395 (2020) 497-506. · DOI · Paper page
- Wakefield, 2010, A network collaboration implementing technology to improve medication dispensing and administration in critical access hospitals, J. Am. Med. Inform. Assoc., 17, 584, 10.1136/jamia.2010.004267 · DOI
- Casey, 2008, Implementation of telepharmacy in rural hospitals: potential for improving medication safety, Upper Midwest Rural Health Research Center
- Petropoulou S., Bekakos M., Gravvanis G., E-prescribing-Telepharmacy, 7th Hellenic European Conference on Computers, Citeseer, 2005, pp. 22-25.
- Edoh, 2017, Smart medicine transportation and medication monitoring system in EPharmacyNet, Int. Rural Elderly Health Informatics Conference (IREHI), 2017, 1
- Xu, 2021, Smartphone-enabled 3D printing of medicines, Int. J. Pharm., 609, 10.1016/j.ijpharm.2021.121199 · DOI
- Awad, 2022, Clinical translation of advanced colonic drug delivery technologies, Adv. Drug Deliv. Rev., 181, 10.1016/j.addr.2021.114076 · DOI
- Holdford, 2013, Adherence and persistence associated with an appointment-based medication synchronization program, J. Am. Pharm. Assoc., 53, 576, 10.1331/JAPhA.2013.13082 · DOI
- Berryman, 2012, Augmented reality: a review, Medical reference services quarterly, 31, 212, 10.1080/02763869.2012.670604 · DOI · Paper page
- Turk M., Fragoso V., Computer Vision for Mobile Augmented Reality, in: G. Hua, X.-S. Hua (Eds.) Mobile Cloud Visual Media Computing: From Interaction to Service, Springer International Publishing, Cham, 2015, pp. 3-42. · DOI
- Feiner, 2002, Augmented reality: A new way of seeing, Sci. Am., 286, 48, 10.1038/scientificamerican0402-48 · DOI
- Masood, 2019, Augmented reality in support of Industry 4.0—Implementation challenges and success factors, Rob. Comput. Integr. Manuf., 58, 181, 10.1016/j.rcim.2019.02.003 · DOI · Paper page
- Habig, 2020, Who can benefit from augmented reality in chemistry? Sex differences in solving stereochemistry problems using augmented reality, British J. Educational Technology, 51, 629, 10.1111/bjet.12891 · DOI · Paper page
- Woolman, 2020, In situ tissue pathology from spatially encoded mass spectrometry classifiers visualized in real time through augmented reality, Chem. Sci., 11, 8723, 10.1039/D0SC02241A · DOI
- Eriksen, 2020, Visualizing 3D Molecular Structures Using an Augmented Reality App, J. Chem. Educ., 97, 1487, 10.1021/acs.jchemed.9b01033 · DOI · Paper page
- Forrest, 2017, Mixed Reality Meets Pharmaceutical Development, J. Pharm. Sci., 106, 3438, 10.1016/j.xphs.2017.08.020 · DOI
- Ingeson, 2018, Microsoft hololens-a mhealth solution for medication adherence, International Workshop on Artificial Intelligence in Health, Springer, 99
- Khor W.S., Baker B., Amin K., Chan A., Patel K., Wong J., Augmented and virtual reality in surgery-the digital surgical environment: applications, limitations and legal pitfalls, Ann Transl Med, 4 (2016) 454-454. · DOI · Paper page
- Setty, 2019, Virtual Reality Inspired Drugs (VRID): the Future Arena of Drug Discovery, SN Comprehensive Clinical Medicine, 1, 745, 10.1007/s42399-019-00117-x · DOI
- Alexiou A., Bouras C., Giannaka E., Kapoulas V., Nani M., Tsiatsos T., Using VR technology to support e-learning: the 3D virtual radiopharmacy laboratory, 24th International Conference on Distributed Computing Systems Workshops, 2004. Proceedings., 2004, pp. 268-273. · doi:10.1109/icdcsw.2004.1284042
- McDowell, 2012, Selecting a pharmacy layout design using a weighted scoring system, Am. J. Health-Syst. Pharm., 69, 796, 10.2146/ajhp100687 · DOI
- Johnston, 2018, Journey to the centre of the cell: Virtual reality immersion into scientific data, Traffic, 19, 105, 10.1111/tra.12538 · DOI
- Keller, 2017, Public Perceptions Regarding Use of Virtual Reality in Health Care: A Social Media Content Analysis Using Facebook, J. Med. Internet Res., 19, 10.2196/jmir.7467 · DOI · Paper page
- Fernández, 2018, Absorption of wireless radiation in the child versus adult brain and eye from cell phone conversation or virtual reality, Environ. Res., 167, 694, 10.1016/j.envres.2018.05.013 · DOI
- Lampton, 2000, Simulator Sickness Symptoms during Team Training in Immersive Virtual Environments, Proc. Human Factors Ergonomics Soc. Annual Meeting, 44, 530, 10.1177/154193120004400512 · doi:10.1177/154193120004400512
- Vincelli, 2002, Virtual reality: a new tool for panic disorder therapy, Expert Rev. Neurother., 2, 377, 10.1586/14737175.2.3.377 · DOI
- Raijada, 2021, Integration of personalized drug delivery systems into digital health, Adv. Drug Deliv. Rev., 176, 10.1016/j.addr.2021.113857 · DOI
- Kaae, 2018, Unintended consequences for patients of future personalized pharmacoprinting, International Journal of Clinical Pharmacy, 40, 321, 10.1007/s11096-018-0596-x · DOI
- Karavasili, 2021, Mucosal drug delivery and 3D printing technologies: A focus on special patient populations, Adv. Drug Deliv. Rev., 176, 113858, 10.1016/j.addr.2021.113858 · DOI
- Eleftheriadis, 2021, Automated digital design for 3D-printed individualized therapies, Int. J. Pharm., 599, 10.1016/j.ijpharm.2021.120437 · doi:10.1016/j.ijpharm.2021.120437
- Pawloski, 2019, A Systematic Review of Clinical Decision Support Systems for Clinical Oncology Practice, J. Natl. Compr. Canc. Netw., 17, 331, 10.6004/jnccn.2018.7104 · DOI · Paper page
- Guo, 2020, Challenges for the evaluation of digital health solutions-A call for innovative evidence generation approaches, NPJ Digit Med, 3, 110, 10.1038/s41746-020-00314-2 · DOI · Paper page
- Ventola, 2019, Virtual Reality in Pharmacy: Opportunities for Clinical, Research, and Educational Applications, P T, 44, 267
Cited by
Dorta-González, P., López-Puig, A. J., Dorta-González, M. I., & González-Betancor, S. M. (2024) · Telematics and Informatics · doi:10.1016/j.tele.2024.102187 · Cited by 36
User Experience of Older People While Using Digital Health Technologies: A Systematic Review
Takano, E., Maruyama, H., Takahashi, T., Mori, K., Nishiyori, K., Morita, Y., Fukuda, T., Kondo, I., & Ishibashi, Y. (2023) · Applied Sciences · doi:10.3390/app132312815 · Cited by 29
Metadata
- Authors
- Trenfield, S. J., Awad, A., McCoubrey, L. E., Elbadawi, M., Goyanes, A., Gaisford, S., & Basit, A. W.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2022-03
- Volume
- 182
- Pages
- 114098
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W4206620032
- Cited by
- 178
- References
- 38
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- Engineering and Physical Sciences Research Council (EP/S009000/1, EP/S023054/1)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.